News2 mins ago
Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP
LONDON, June 15, 2023 /PRNewswire/ — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. With this launch,...
